Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma
NCT06940700 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2025-04-23
Summary
To evaluate the efficacy and safety of SHR-4597 inhalants in adults with asthma: a multicenter, randomized, open-label, positive-controlled Phase II clinical study
Conditions
Interventions
- DRUG
-
SHR4597
SHR4597
- DRUG
-
Budesonide inhalant
Budesonide inhalant
Sponsors & Collaborators
-
Guangdong Hengrui Pharmaceutical Co., Ltd
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-30
- Primary Completion
- 2025-10-31
- Completion
- 2025-12-31
Countries
- China
Study Locations
More Related Trials
-
The Asthma Control Rate Achieved by Budesonide/Formoterol in Clinical Practice in China
NCT01785901 ·Status: COMPLETED
-
A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma
NCT06471257 ·Status: RECRUITING ·Phase: PHASE3
-
A Trial of SHR-1703 in Asthma
NCT05042401 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne Pollution
NCT04132570 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics, Pharmacodynamics, Safety, and Preliminary Efficacy of Subcutaneous Injection of SHR-1905 in Adolescent Asthmatic Subjects - an Open-label, Single-dose Phase II Clinical Study
NCT06786455 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma
NCT07098403 ·Status: RECRUITING ·Phase: PHASE3
-
Titratable Dosing in Moderate to Severe Asthmatics
NCT00651768 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma
NCT03769090 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered Dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma
NCT03847896 ·Status: COMPLETED ·Phase: PHASE3
-
BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient
NCT05322707 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma
NCT01687283 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma
NCT05593250 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Study in Healthy Subjects
NCT04772365 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of SHR-1703 in Healthy Adults
NCT04480762 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria Tablets)
NCT06895460 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children
NCT00522782 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Inhaled Glucocorticosteroid Administration in Asthma Patients
NCT00559689 ·Status: COMPLETED
-
A Study to Evaluate the Pharmacodynamic, Efficacy and Safety of SHR-1703 in Asthma Patients With Eosinophil Phenotype
NCT05522439 ·Status: COMPLETED ·Phase: PHASE2
-
A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population
NCT06419413 ·Status: RECRUITING
-
Asthma Biomarkers for Predicting Response to Therapy
NCT01973751 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy of Budesonide/Formoterol in Cough Variant Asthma
NCT04171180 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients
NCT00837967 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)
NCT03528577 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing Budesonide Hydrofluoroalkane (HFA) vs Chlorofluorocarbon (CFC) Pressurized Metered Dose Inhalers (pMDI) in Patients With Mild to Moderate Asthma
NCT00667992 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
NCT07324707 ·Status: RECRUITING ·Phase: PHASE2